According to a new report by Polaris Market Research, the global large molecule drug substance CDMO market was valued at USD 53.79 billion in 2025 and is projected to reach USD 102.36 billion by 2034, expanding at a CAGR of 7.41% over the forecast period. Growt0068 is underpinned by rising global approvals of biologic drugs, increasing healthcare expenditure, and accelerating adoption...